Stockreport

Iovance Bio up 19% ahead of data presentation on TIL therapy in lung cancer [Seeking Alpha]

Iovance Biotherapeutics, Inc.  (IOVA) 
Last iovance biotherapeutics, inc. earnings: 2/25 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: iovance.com
PDF Iovance Biotherapeutics (IOVA+19.1%Phase 1 dataThe title tips the outcome:Durable complete responses to adoptive cell transfer using [TIL] in non-small cell lung cancer: [Read more]